LifeStance Health Group Management
Management criteria checks 2/4
LifeStance Health Group's CEO is Dave Bourdon, appointed in Mar 2025, has a tenure of less than a year. total yearly compensation is $3.45M, comprised of 14.5% salary and 85.5% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $4.88M. The average tenure of the management team and the board of directors is 1.3 years and 5 years respectively.
Key information
Dave Bourdon
Chief executive officer
US$3.4m
Total compensation
| CEO salary percentage | 14.51% |
| CEO tenure | less than a year |
| CEO ownership | 0.2% |
| Management average tenure | 1.3yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion
Apr 22
Planned Expansions And Clinician-Focused Initiatives Will Improve Future Productivity
Standardizing operations and digital initiatives should enhance efficiency, improve net margins, and boost revenue per visit.LifeStance Health Group (NASDAQ:LFST) Is Carrying A Fair Bit Of Debt
Mar 21
LifeStance Health Group, Inc.'s (NASDAQ:LFST) Share Price Matching Investor Opinion
Jan 16Should You Think About Buying LifeStance Health Group, Inc. (NASDAQ:LFST) Now?
Dec 26LifeStance Health Group (NASDAQ:LFST) Is Making Moderate Use Of Debt
Dec 05Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)
Nov 10Why Investors Shouldn't Be Surprised By LifeStance Health Group, Inc.'s (NASDAQ:LFST) P/S
Sep 26Here's Why LifeStance Health Group (NASDAQ:LFST) Can Afford Some Debt
Sep 02LifeStance Health Group, Inc. (NASDAQ:LFST) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 11LifeStance Health Group, Inc.'s (NASDAQ:LFST) Intrinsic Value Is Potentially 63% Above Its Share Price
Jul 15With LifeStance Health Group, Inc. (NASDAQ:LFST) It Looks Like You'll Get What You Pay For
Jun 07LifeStance: Selloff Opens Buying Opportunity Thanks To Price/Value Dislocation
May 23LifeStance Health Group, Inc. (NASDAQ:LFST) Analysts Are Pretty Bullish On The Stock After Recent Results
May 12Why LifeStance Health Group, Inc. (NASDAQ:LFST) Could Be Worth Watching
May 06Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)
Mar 23LifeStance Health Group, Inc. (NASDAQ:LFST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.50
Mar 02LifeStance Q4 Earnings Review: Monetizing Mental Health Virtually Is Problematic
Feb 29Does LifeStance Health Group (NASDAQ:LFST) Have A Healthy Balance Sheet?
Feb 28LifeStance Health Group, Inc.'s (NASDAQ:LFST) P/S Still Appears To Be Reasonable
Jan 23What Is LifeStance Health Group, Inc.'s (NASDAQ:LFST) Share Price Doing?
Jul 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$36m |
| Dec 31 2024 | US$3m | US$500k | -US$57m |
| Sep 30 2024 | n/a | n/a | -US$95m |
| Jun 30 2024 | n/a | n/a | -US$151m |
| Mar 31 2024 | n/a | n/a | -US$173m |
| Dec 31 2023 | US$2m | US$500k | -US$186m |
| Sep 30 2023 | n/a | n/a | -US$188m |
| Jun 30 2023 | n/a | n/a | -US$164m |
| Mar 31 2023 | n/a | n/a | -US$187m |
| Dec 31 2022 | US$5m | US$52k | -US$216m |
Compensation vs Market: Dave's total compensation ($USD3.45M) is below average for companies of similar size in the US market ($USD6.25M).
Compensation vs Earnings: Dave's compensation has increased whilst the company is unprofitable.
CEO
Dave Bourdon (54 yo)
Mr. David Patrick Bourdon, also known as Dave, had been Chief Financial Officer and Treasurer of LifeStance Health Group, Inc. since joining in November 10, 2022 until March 17, 2025 and serves as its Chie...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 2.7yrs | US$10.20m | 0.87% $ 18.5m | |
| CEO & Director | less than a year | US$3.45m | 0.23% $ 4.9m | |
| Chief Legal Officer & Secretary | 8.3yrs | US$2.61m | 0.89% $ 19.1m | |
| Chief People Officer | 2.3yrs | US$1.67m | 0.096% $ 2.1m | |
| Chief Digital Officer | 4.6yrs | US$2.76m | 0.37% $ 8.0m | |
| CFO & Treasurer | less than a year | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Director of Public Relations | no data | no data | no data | |
| Chief Medical Officer | 1.3yrs | no data | 0.033% $ 710.5k | |
| Executive Vice President of Shared Services | 1.3yrs | no data | no data | |
| Executive Vice President of Practice Operations | 2.7yrs | no data | 0.087% $ 1.9m | |
| Senior VP & Chief Strategy Officer | 1.3yrs | no data | no data |
Experienced Management: LFST's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 2.7yrs | US$10.20m | 0.87% $ 18.5m | |
| CEO & Director | less than a year | US$3.45m | 0.23% $ 4.9m | |
| Independent Director | 7.3yrs | US$270.00k | 0.29% $ 6.2m | |
| Independent Director | 5yrs | no data | no data | |
| Independent Director | 8.3yrs | no data | no data | |
| Independent Director | 1.2yrs | US$440.65k | no data | |
| Independent Director | 8.3yrs | no data | no data | |
| Independent Director | 8.3yrs | US$250.00k | 0.77% $ 16.4m | |
| Independent Director | 4.8yrs | US$250.00k | 0.11% $ 2.3m | |
| Independent Director | 5yrs | no data | no data | |
| Independent Director | 3.8yrs | US$250.00k | 0.022% $ 469.7k |
Experienced Board: LFST's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/27 14:19 |
| End of Day Share Price | 2025/05/27 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LifeStance Health Group, Inc. is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephanie Davis | Barclays |
| Richard Close | Canaccord Genuity |
| Jamie Perse | Goldman Sachs |